United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions).

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), intrinsic factor (unii: 70bt6oqt2q) (intrinsic factor - unii:70bt6oqt2q), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

Australia - English - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - folic acid, quantity: 0.35 mg; ferrous fumarate, quantity: 310 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; titanium dioxide; iron oxide red; microcrystalline cellulose; purified talc; sodium starch glycollate type a; hypromellose; magnesium stearate; triethyl citrate - to be given as a source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias. it may also be used for the prevention and treatment of these conditions during pregnancy.

United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a) - ferrous fumarate 191.2 mg - description: each capsule contains: ferrous fumarate (anhydrous) ..................................191.1 mg polysaccharide iron complex..................................... 135.9 mg (equivalent to about 125 mg of elemental iron) folic acid ....................................................................................1 mg ascorbic acid (from proascorb c‡) ................................ 40 mg vitamin b3 (from proascorb c‡) ........................................3 mg clinical pharmacology: integra ftm is unique in that it utilizes two (2) different forms of iron, i.e., ferrous fumarate and polysaccharide iron complex (as cell-contracted akaganèite), making available a total of 125 mg of elemental iron per capsule as follows: ferrous fumarate (anhydrous)    191.1 mg polysaccharide iron complex (pic)    135.9 mg ferrous fumarate: provides about 62.5 mg of elemental iron per dose. ferrous fumarate is an anhydrous salt of a combination of ferrous iron and fumaric acid, containing 33% of iron per weight.

United States - English - NLM (National Library of Medicine)

u.s. pharmaceutical corporation - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), calcium pantothenate (unii: 568e - ferrous fumarate 191.2 mg - description: each capsule contains: ferrous fumarate (anhydrous) ......191.1 mg polysaccharide iron complex... 135.9 mg (equivalent to about 125 mg of elemental iron) vitamin c (from proascorb c‡)....210 mg folic acid .....1 mg thiamine mononitrate (b1)...5 mg riboflavin (b2)....5 mg niacin (b3) . 20 mg d-calcium pantothenate (b5)..7 mg pyridoxine hcl (b6) ...25 mg biotin (b7)......300 mcg cyanocobalamin (b12) .. 10 mcg clinical pharmacology: integra plustm is unique in that it utilizes two (2) different forms of iron, i.e., ferrous fumarate and polysaccharide iron complex (as cell-contracted akaganèite), making available a total of 125 mg of elemental iron per capsule as follows: ferrous fumarate (anhydrous)    191.1 mg polysaccharide iron complex (pic)    135.9 mg subclinical b-group vitamin deficiencies have greatly increased in recent years, due to changes in dietetic habits, increase in the use of sugar, and the excessive milling of flour and cereals. with thiamine deficiencies in a healthy populous,